Immune Complex–Mediated Small Vessel Vasculitis

91 Immune Complex–Mediated Small Vessel Vasculitis

Key Points

Vasculitis mediated by immune complexes (ICs) includes a heterogeneous group of disorders linked by inefficient or dysregulated clearance of ICs.

The most common types of IC-mediated vasculitis are hypersensitivity vasculitis, Henoch-Schönlein purpura (HSP), and mixed cryoglobulinemia. Rarer forms of this condition include hypocomplementemic urticarial vasculitis and erythema elevatum diutinum.

Connective tissue disorders such as systemic lupus erythematosus, Sjögren’s syndrome, and rheumatoid arthritis can be associated with IC-mediated vasculitis.

Cutaneous involvement of small blood vessels is the most prominent feature in the majority of cases, but extracutaneous involvement occurs in some forms.

The classic cutaneous finding in small vessel vasculitis is palpable purpura, but a variety of other skin lesions may be found including pustules, vesicles, urticaria, and small ulcerations.

Direct immunofluorescence studies of involved blood vessels demonstrate characteristic types and patterns of immunoglobulin (Ig) and complement deposition.

Hypersensitivity vasculitis usually results from a reaction to a medication or an infection.

HSP is associated with purpura, arthritis, glomerulonephritis, and colicky abdominal pain. IgA deposition is found within blood vessel walls.

Cryoglobulinemic vasculitis is most often associated with long-standing hepatitis C virus infection. The term mixed cryoglobulinemia is sometimes used for this disorder because the immunoreactants involved in the disease include both IgG and IgM.

The inflammation within blood vessel walls that characterizes vasculitis frequently leads to cellular destruction, damage to the vascular structures, compromise of blood flow to organs, and organ dysfunction. It has been known for decades that immune complex (IC)–mediated mechanisms play critical roles in many forms of systemic vasculitis, particularly those that involve primarily small blood vessels. As described in Chapter 87, the use of horse serum and sulfonamides as therapeutic agents for infectious diseases in the early 1900s frequently led to small vessel vasculitis on the basis of serum sickness or hypersensitivity phenomena. Hypersensitivity angiitis, often confused with the pauci-immune form of vasculitis now termed microscopic polyangiitis (see Chapter 89),1 was one of five disorders included in the original classification of the vasculitides in 1952.2

This chapter focuses on forms of small vessel vasculitis that are mediated by IC deposition. These disorders include hypersensitivity vasculitis, Henoch-Schönlein purpura (HSP), mixed cryoglobulinemia, hypocomplementemic urticarial vasculitis, and erythema elevatum diutinum. In addition, forms of vasculitis associated with connective tissue diseases, particularly systemic lupus erythematosus (SLE), Sjögren’s syndrome, and rheumatoid vasculitis, are discussed briefly. Anti–glomerular basement membrane disease and the pauci-immune forms of vasculitis such as those associated with antineutrophil cytoplasmic antibodies, are discussed elsewhere (see Chapter 89). Throughout this chapter, the terms vasculitis and angiitis are used interchangeably when referring to inflammation involving small blood vessels (capillaries, venules, arterioles).

Because all forms of IC-mediated vasculitis share certain elements of pathogenesis, have many cutaneous findings in common, and have overlapping differential diagnoses, these aspects of the disorders are considered together. The epidemiology, cause, distinctive pathophysiologic mechanisms, unique clinical features, and approaches to treatment are discussed separately for each condition. Treatments are also summarized in Table 91-1.

Table 91-1 Potential Treatment Approaches for Different Forms of Immune Complex–Mediated Vasculitis

Disease Preferred Treatment Approach
Hypersensitivity vasculitis
Henoch-Schönlein purpura
Hypocomplementemic urticarial vasculitis
Erythema elevatum diutinum
Connective tissue disease
Rheumatoid vasculitis


Arthus Reaction

The Arthus reaction, described after the injection of horse serum into rabbits, forms the basis of our understanding of IC-mediated diseases.3 The formation of ICs in the Arthus reaction initiates complement activation and an influx of inflammatory cells, followed by thrombus formation and hemorrhagic infarction in the areas of most intense inflammation. ICs, formed by the combination of antibody and antigen, are continuously created (and usually cleared swiftly and efficiently) by the reticuloendothelial system as a means of neutralizing foreign antigens. Under some circumstances, however, ICs escape clearance and become deposited within joints, blood vessels, and other tissues, inciting inflammation and causing disease. ICs deposited in the blood vessel walls lead to vasculitis. Similarly, those deposited within small blood vessels of the kidney—the glomeruli—cause glomerulonephritis.4

Cutaneous Manifestations

Small blood vessels generally include capillaries, postcapillary venules, and nonmuscular arterioles—vessels that are typically less than 50 µm in diameter. These are found principally within the superficial papillary dermis (Figure 91-1). Medium-sized blood vessels, those between 50 and 150 µm in diameter, contain muscular walls and are located principally in the deep reticular dermis, near the junction of the dermis and subcutaneous tissues. Vessels larger than 150 µm in diameter are not commonly found in the skin.

Figure 91-1, which demonstrates the location and size of blood vessels involved in various types of cutaneous vasculitis, illustrates the types of blood vessels affected by several forms of IC-mediated disease. A blood vessel’s size correlates closely with its depth in the skin layers: The larger the vessel, the deeper its location. Although telltale signs of vasculitis may be evident on inspection of the skin’s surface, the epidermis is avascular. Therefore the pathologic findings in cutaneous vasculitides lie within the dermis and subcutaneous tissues.

Palpable purpura, synonymous with small vessel vasculitis, is the most common cutaneous finding in IC-mediated vasculitis (Figure 91-2). Purpuric lesions result from the extravasation of erythrocytes through damaged blood vessel walls into tissue. Many other skin manifestations are possible in these conditions including vesicles, pustules, urticaria, superficial ulcerations, nonpalpable lesions (macules and patches), and splinter hemorrhages (Figure 91-3). These lesions frequently occur in combination, and careful examination usually reveals a purpuric component. Purpuric lesions do not blanch when pressure is applied to the skin. Following resolution, purpuric lesions may leave postinflammatory hyperpigmentation, particularly if repeated bouts occur (see Figure 91-3F).

In IC-mediated vasculitis, purpuric lesions are usually distributed in a symmetric fashion over dependent regions of the body, particularly the lower legs, because of the increased hydrostatic pressure in these areas. Purpuric lesions are not always palpable to the touch, and the existence of palpable purpura does not necessarily imply an IC-mediated pathophysiology; pauci-immune forms of vasculitis such as granulomatosis with polyangiitis (GPA) (formerly Wegener’s granulomatosis), microscopic polyangiitis, and Churg-Strauss syndrome, for example, may present with identical skin findings (albeit distinctive histopathology; see Chapter 89).

Pathologic Features

Full pathologic assessment of cutaneous vasculitis involves examination of a skin biopsy specimen by both light microscopy and direct immunofluorescence (DIF). DIF is a particularly critical procedure in the evaluation of small vessel vasculitides. DIF studies must be planned at the time the biopsy is performed because they require a fresh skin biopsy sample.

Light Microscopy

Figure 91-4A displays the light microscopy findings of cutaneous vasculitis. The optimal time for skin biopsy is 24 to 48 hours after the appearance of a lesion. Biopsies should be obtained from a nonulcerated site. For ulcerated lesions—usually more of an issue with medium vessel vasculitides—biopsies should be taken from the ulcer’s edge. The cellular infiltrates in cutaneous vasculitis are usually made up of a combination of neutrophils and lymphocytes, but most cases demonstrate a predominance of one cell type or the other. Lymphocyte-rich infiltrates may be seen in specimens taken from either new (<12 hours) or old (>48 hours) lesions, regardless of the underlying type of vasculitis. Even in connective tissue disorders such as Sjögren’s syndrome, the typical finding is a leukocytoclastic vasculitis rather than a lymphocytic vasculitis.5

The essential histologic feature in any form of cutaneous vasculitis is the disruption of blood vessel architecture by an inflammatory infiltrate within and around the vessel walls. Endothelial swelling and proliferation, leukocytoclasis (degranulation of neutrophils, leading to the production of nuclear “dust”; see Figure 91-4), and extravasation of erythrocytes may be evident in the biopsy but are not essential to the diagnosis.

Differential Diagnosis

The differential diagnosis of IC-mediated small vessel vasculitis is shown in Table 91-2. There are three main groups of disorders in the differential diagnosis of IC-mediated small vessel vasculitis: other forms of IC-mediated disorders, forms of small vessel vasculitis that are not mediated through ICs, and vasculitis mimickers that involve small blood vessels. A diagnostic algorithm that includes the critical laboratory and radiographic tests is shown in Figure 91-5.

Table 91-2 Differential Diagnosis of Immune Complex–Mediated Vasculitis

Immune Complex–Mediated Vasculitides

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 3, 2016 | Posted by in RHEUMATOLOGY | Comments Off on Immune Complex–Mediated Small Vessel Vasculitis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access